Table of contents of journal:

Results: 16

The coagulation pathway and antithrombotic strategies

Authors: Leblond, L Winocour, PD

Citation: L. Leblond et Pd. Winocour, The coagulation pathway and antithrombotic strategies, HANDB EXP P, 132, 1999, pp. 1-39

New developments in the molecular biology of coagulation and fibrinolysis

Authors: Carmeliet, P Collen, D

Citation: P. Carmeliet et D. Collen, New developments in the molecular biology of coagulation and fibrinolysis, HANDB EXP P, 132, 1999, pp. 41-76

Epidemiology of arterial and venous thrombosis

Authors: Kee, F

Citation: F. Kee, Epidemiology of arterial and venous thrombosis, HANDB EXP P, 132, 1999, pp. 77-99

In vivo models of thrombosis

Authors: Chi, L Rebello, S Lucchesi, BR

Citation: L. Chi et al., In vivo models of thrombosis, HANDB EXP P, 132, 1999, pp. 101-127

Monitoring antithrombotic therapy

Authors: Cuthbert, RJG

Citation: Rjg. Cuthbert, Monitoring antithrombotic therapy, HANDB EXP P, 132, 1999, pp. 129-155

Use of transgenic mice in the study of thrombosis and hemostasis

Authors: Pearson, JM Ginsburg, D

Citation: Jm. Pearson et D. Ginsburg, Use of transgenic mice in the study of thrombosis and hemostasis, HANDB EXP P, 132, 1999, pp. 157-174

Current antiplatelet therapy

Authors: Jakubowski, JA Jordan, RE Weisman, HF

Citation: Ja. Jakubowski et al., Current antiplatelet therapy, HANDB EXP P, 132, 1999, pp. 175-208

Platelet membrane receptors and signalling pathways: New therapeutic targets

Authors: Watson, SP Keeling, D Hollenberg, MD

Citation: Sp. Watson et al., Platelet membrane receptors and signalling pathways: New therapeutic targets, HANDB EXP P, 132, 1999, pp. 209-257

Heparin and other indirect antithrombin agents

Authors: Bell, WR Hennebry, TA

Citation: Wr. Bell et Ta. Hennebry, Heparin and other indirect antithrombin agents, HANDB EXP P, 132, 1999, pp. 259-303

Low molecular weight heparin

Authors: Pineo, GF Hull, RD

Citation: Gf. Pineo et Rd. Hull, Low molecular weight heparin, HANDB EXP P, 132, 1999, pp. 305-329

Parenteral direct antithrombins

Authors: Lauer, MA Lincoff, AM

Citation: Ma. Lauer et Am. Lincoff, Parenteral direct antithrombins, HANDB EXP P, 132, 1999, pp. 331-352

Anticoagulant therapy with warfarin for thrombotic disorders

Authors: Harker, LA

Citation: La. Harker, Anticoagulant therapy with warfarin for thrombotic disorders, HANDB EXP P, 132, 1999, pp. 353-366

Oral thrombin inhibitors: Challenges and progress

Authors: Kimball, SD

Citation: Sd. Kimball, Oral thrombin inhibitors: Challenges and progress, HANDB EXP P, 132, 1999, pp. 367-396

Inhibitors of factor Xa

Authors: Kunitada, S Nagahara, T Hara, T

Citation: S. Kunitada et al., Inhibitors of factor Xa, HANDB EXP P, 132, 1999, pp. 397-420

Inhibitors of tissue factor/factor VIIa

Authors: Gallagher, KP Mertz, TE Chi, L Rubin, JR Uprichard, ACG

Citation: Kp. Gallagher et al., Inhibitors of tissue factor/factor VIIa, HANDB EXP P, 132, 1999, pp. 421-445

Natural anticoagulants and their pathways

Authors: Esmon, CT

Citation: Ct. Esmon, Natural anticoagulants and their pathways, HANDB EXP P, 132, 1999, pp. 447-476

Risultati: 1-16 |